Title : 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial.

Pub. Date : 2020 Dec

PMID : 32740481






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 OBJECTIVE: To examine responder rates and vasomotor symptom-free days with oral 17beta-estradiol/progesterone (E2/P4; TX-001HR) versus placebo in the REPLENISH trial. Progesterone cystatin 12, pseudogene Homo sapiens